# Local Bounti Corporation: financial statements, quarterly

LOCL · NYSE · CIK 1840780 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/locl.md) · [Financials](/companies/locl/financials.md) · [Filings](/companies/locl/filings.md) · [Insiders](/companies/locl/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/locl/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [6.8](/filings/0001840780-24-000028.md) | [6.9 d](/filings/0001840780-25-000009.md) | [8.4](/filings/0001840780-25-000015.md) | [9.4](/filings/0001840780-25-000037.md) | [10.2](/filings/0001628280-25-052331.md) | [10.1 d](/filings/0001628280-26-021706.md) | [11.6](/filings/0001628280-26-035317.md) | [12.1](/filings/0001628280-26-056162.md) | [12.2](/filings/0001628280-25-052331.md) | [12.5 d](/filings/0001628280-26-021706.md) | [13.3](/filings/0001628280-26-035317.md) | [13.9](/filings/0001628280-26-056162.md) |
| Cost of revenue | $m | [6.4](/filings/0001840780-24-000028.md) | [6.2 d](/filings/0001840780-25-000009.md) | [7.6](/filings/0001840780-25-000015.md) | [8.1](/filings/0001840780-25-000037.md) | [8.8](/filings/0001628280-25-052331.md) | [9.5 d](/filings/0001628280-26-021706.md) | [10.1](/filings/0001628280-26-035317.md) | [10.6](/filings/0001628280-26-056162.md) | [10.8](/filings/0001628280-25-052331.md) | [10.9 d](/filings/0001628280-26-021706.md) | [11.8](/filings/0001628280-26-035317.md) | [12.8](/filings/0001628280-26-056162.md) |
| Gross profit | $m | [0.4](/filings/0001840780-24-000028.md) | [0.7 d](/filings/0001840780-25-000009.md) | [0.8](/filings/0001840780-25-000015.md) | [1.4](/filings/0001840780-25-000037.md) | [1.4](/filings/0001628280-25-052331.md) | [0.5 d](/filings/0001628280-26-021706.md) | [1.5](/filings/0001628280-26-035317.md) | [1.5](/filings/0001628280-26-056162.md) | [1.4](/filings/0001628280-25-052331.md) | [1.5 d](/filings/0001628280-26-021706.md) | [1.5](/filings/0001628280-26-035317.md) | [1.0](/filings/0001628280-26-056162.md) |
| Research and development | $m | [5.0](/filings/0001840780-24-000028.md) | [4.0 d](/filings/0001840780-25-000009.md) | [3.5](/filings/0001840780-25-000015.md) | [4.5](/filings/0001840780-25-000037.md) | [7.1](/filings/0001628280-25-052331.md) | [7.2 d](/filings/0001628280-26-021706.md) | [7.0](/filings/0001628280-26-035317.md) | [6.5](/filings/0001628280-26-056162.md) | [6.7](/filings/0001628280-25-052331.md) | [5.4 d](/filings/0001628280-26-021706.md) | [5.7](/filings/0001628280-26-035317.md) | [4.6](/filings/0001628280-26-056162.md) |
| Selling, general and administrative | $m | [14.4](/filings/0001840780-24-000028.md) | [17.5 d](/filings/0001840780-25-000009.md) | [7.6](/filings/0001840780-24-000017.md) | [10.7](/filings/0001840780-24-000024.md) | [12.3](/filings/0001840780-24-000028.md) | [10.1 d](/filings/0001840780-25-000009.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [(19.0)](/filings/0001840780-24-000028.md) | [(59.3) d](/filings/0001840780-25-000009.md) | [(10.3)](/filings/0001840780-25-000015.md) | [(13.9)](/filings/0001840780-25-000037.md) | [(18.0)](/filings/0001628280-25-052331.md) | [(16.8) d](/filings/0001628280-26-021706.md) | [(15.7)](/filings/0001628280-26-035317.md) | [(15.5)](/filings/0001628280-26-056162.md) | [(18.2)](/filings/0001628280-25-052331.md) | [(13.2) d](/filings/0001628280-26-021706.md) | [(13.9)](/filings/0001628280-26-035317.md) | [(13.9)](/filings/0001628280-26-056162.md) |
| Income tax | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [(24.3)](/filings/0001840780-24-000028.md) | [(65.6) d](/filings/0001840780-25-000009.md) | [(24.1)](/filings/0001628280-25-052331.md) | [(25.3)](/filings/0001628280-25-052331.md) | [(34.3)](/filings/0001628280-25-052331.md) | [(36.3) d](/filings/0001628280-26-021706.md) | [(37.7)](/filings/0001628280-26-056162.md) | [(21.6)](/filings/0001628280-26-056162.md) | [(26.4)](/filings/0001628280-25-052331.md) | [(8.7) d](/filings/0001628280-26-021706.md) | [(12.7)](/filings/0001628280-26-056162.md) | [(19.8)](/filings/0001628280-26-056162.md) |
| Diluted EPS | $ per share | [(3.02)](/filings/0001840780-24-000028.md) | not reported | [(2.89)](/filings/0001840780-25-000015.md) | [(3.00)](/filings/0001840780-25-000037.md) | [(4.01)](/filings/0001628280-25-052331.md) | not reported | [(4.32)](/filings/0001628280-26-035317.md) | [(1.63)](/filings/0001628280-26-056162.md) | [(1.18)](/filings/0001628280-25-052331.md) | not reported | [(0.53)](/filings/0001628280-26-035317.md) | [(0.68)](/filings/0001628280-26-056162.md) |
| Basic EPS | $ per share | [(3.02)](/filings/0001840780-24-000028.md) | not reported | [(2.89)](/filings/0001840780-25-000015.md) | [(3.00)](/filings/0001840780-25-000037.md) | [(4.01)](/filings/0001628280-25-052331.md) | not reported | [(4.32)](/filings/0001628280-26-035317.md) | [(1.63)](/filings/0001628280-26-056162.md) | [(1.18)](/filings/0001628280-25-052331.md) | not reported | [(0.53)](/filings/0001628280-26-035317.md) | [(0.68)](/filings/0001628280-26-056162.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: not reported
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [11.8](/filings/0001840780-24-000028.md) | [10.3](/filings/0001840780-25-000009.md) | [8.2](/filings/0001840780-25-000015.md) | [9.7](/filings/0001840780-25-000037.md) | [0.3](/filings/0001628280-25-052331.md) | [0.9](/filings/0001628280-26-021706.md) | [18.0](/filings/0001628280-26-035317.md) | [5.3](/filings/0001628280-26-056162.md) | [6.2](/filings/0001628280-25-052331.md) | [4.2](/filings/0001628280-26-056162.md) | [12.3](/filings/0001628280-26-035317.md) | [3.6](/filings/0001628280-26-056162.md) |
| Current assets | $m | [27.8](/filings/0001840780-23-000045.md) | [27.0](/filings/0001840780-25-000009.md) | [25.7](/filings/0001840780-24-000017.md) | [26.8](/filings/0001840780-24-000024.md) | [17.3](/filings/0001840780-24-000028.md) | [18.8](/filings/0001628280-26-021706.md) | [40.6](/filings/0001840780-25-000015.md) | [24.9](/filings/0001840780-25-000037.md) | [24.1](/filings/0001628280-25-052331.md) | [22.0](/filings/0001628280-26-056162.md) | [30.2](/filings/0001628280-26-035317.md) | [23.3](/filings/0001628280-26-056162.md) |
| Total assets | $m | [377](/filings/0001840780-23-000045.md) | [382](/filings/0001840780-25-000009.md) | [413](/filings/0001840780-24-000017.md) | [438](/filings/0001840780-24-000024.md) | [431](/filings/0001840780-24-000028.md) | [428](/filings/0001628280-26-021706.md) | [447](/filings/0001840780-25-000015.md) | [427](/filings/0001840780-25-000037.md) | [418](/filings/0001628280-25-052331.md) | [410](/filings/0001628280-26-056162.md) | [414](/filings/0001628280-26-035317.md) | [403](/filings/0001628280-26-056162.md) |
| Current liabilities | $m | [24.8](/filings/0001840780-23-000045.md) | [31.9](/filings/0001840780-25-000009.md) | [32.2](/filings/0001840780-24-000017.md) | [43.5](/filings/0001840780-24-000024.md) | [53.1](/filings/0001840780-24-000028.md) | [55.4](/filings/0001628280-26-021706.md) | [20.0](/filings/0001840780-25-000015.md) | [19.4](/filings/0001840780-25-000037.md) | [14.3](/filings/0001628280-25-052331.md) | [16.3](/filings/0001628280-26-056162.md) | [18.7](/filings/0001628280-26-035317.md) | [21.7](/filings/0001628280-26-056162.md) |
| Total liabilities | $m | [300](/filings/0001840780-23-000045.md) | [366](/filings/0001840780-25-000009.md) | [423](/filings/0001840780-24-000017.md) | [471](/filings/0001840780-24-000024.md) | [496](/filings/0001840780-24-000028.md) | [529](/filings/0001628280-26-021706.md) | [560](/filings/0001840780-25-000015.md) | [559](/filings/0001840780-25-000037.md) | [576](/filings/0001628280-25-052331.md) | [577](/filings/0001628280-26-056162.md) | [592](/filings/0001628280-26-035317.md) | [600](/filings/0001628280-26-056162.md) |
| Long-term debt | $m | [217](/filings/0001840780-23-000045.md) | [278](/filings/0001840780-25-000009.md) | [330](/filings/0001840780-24-000017.md) | [367](/filings/0001840780-24-000024.md) | [385](/filings/0001840780-24-000028.md) | [417](/filings/0001628280-26-021706.md) | [480](/filings/0001840780-25-000015.md) | [478](/filings/0001840780-25-000037.md) | [485](/filings/0001628280-25-052331.md) | [483](/filings/0001628280-26-056162.md) | [491](/filings/0001628280-26-035317.md) | [489](/filings/0001628280-26-056162.md) |
| Current portion of debt | $m | not reported | [0.0](/filings/0001840780-25-000009.md) | not reported | [6.7](/filings/0001840780-24-000024.md) | [13.5](/filings/0001840780-24-000028.md) | [20.2](/filings/0001628280-26-021706.md) | [0.0](/filings/0001840780-25-000015.md) | [0.0](/filings/0001840780-25-000037.md) | [0.0](/filings/0001628280-25-052331.md) | [0.0](/filings/0001628280-26-021706.md) | not reported | not reported |
| Short-term borrowings | $m | not reported | [0.0](/filings/0001840780-25-000009.md) | not reported | [6.7](/filings/0001840780-24-000024.md) | [13.5](/filings/0001840780-24-000028.md) | [20.2](/filings/0001628280-26-021706.md) | [0.0](/filings/0001840780-25-000015.md) | [0.0](/filings/0001840780-25-000037.md) | [0.0](/filings/0001628280-25-052331.md) | [0.0](/filings/0001628280-26-021706.md) | not reported | not reported |
| Shareholders' equity | $m | [77.8](/filings/0001840780-24-000028.md) | [15.3](/filings/0001628280-26-021706.md) | [(9.4)](/filings/0001628280-25-052331.md) | [(32.8)](/filings/0001628280-25-052331.md) | [(65.6)](/filings/0001628280-25-052331.md) | [(101)](/filings/0001628280-26-056162.md) | [(134)](/filings/0001628280-26-056162.md) | [(133)](/filings/0001628280-26-056162.md) | [(158)](/filings/0001628280-25-052331.md) | [(166)](/filings/0001628280-26-056162.md) | [(178)](/filings/0001628280-26-056162.md) | [(197)](/filings/0001628280-26-056162.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(9.9) d](/filings/0001840780-24-000028.md) | [(7.2) d](/filings/0001840780-25-000009.md) | [(7.1)](/filings/0001840780-25-000015.md) | [(4.0) d](/filings/0001840780-25-000037.md) | [(17.2) d](/filings/0001628280-25-052331.md) | [1.2 d](/filings/0001628280-26-021706.md) | [(9.6)](/filings/0001628280-26-035317.md) | [(8.7) d](/filings/0001628280-26-056162.md) | [(8.9) d](/filings/0001628280-25-052331.md) | [(3.1) d](/filings/0001628280-26-021706.md) | [(6.1)](/filings/0001628280-26-035317.md) | [(7.4) d](/filings/0001628280-26-056162.md) |
| Capital expenditure | $m | [41.1 d](/filings/0001840780-24-000028.md) | [45.0 d](/filings/0001840780-25-000009.md) | [35.0](/filings/0001840780-25-000015.md) | [24.8 d](/filings/0001840780-25-000037.md) | [12.8 d](/filings/0001628280-25-052331.md) | [9.8 d](/filings/0001628280-26-021706.md) | [5.0](/filings/0001628280-26-035317.md) | [5.9 d](/filings/0001628280-26-056162.md) | [1.2 d](/filings/0001628280-25-052331.md) | [(0.5) d](/filings/0001628280-26-021706.md) | [1.1](/filings/0001628280-26-035317.md) | [1.0 d](/filings/0001628280-26-056162.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [6.9](/filings/0001840780-23-000045.md) | [7.7](/filings/0001840780-24-000017.md) | [7.9](/filings/0001840780-24-000024.md) | [8.0](/filings/0001840780-24-000028.md) | [8.3](/filings/0001840780-25-000015.md) | [8.4](/filings/0001840780-25-000037.md) | [8.6](/filings/0001628280-25-052331.md) | [8.8](/filings/0001628280-26-035317.md) | [13.3](/filings/0001628280-26-056162.md) | [22.5](/filings/0001628280-25-052331.md) | [24.1](/filings/0001628280-26-035317.md) | [29.1](/filings/0001628280-26-056162.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 23,380,119 at 2026-08-07, from the cover of the [10-Q filed 2026-08-12](/filings/0001628280-26-056162.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.